 Connection
Jason Farrar to Dengue
This is a "connection" page, showing publications Jason Farrar has written about Dengue.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.551 |
|
|
|
-
Wilder-Smith A, Vannice KS, Hombach J, Farrar J, Nolan T. Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine. J Infect Dis. 2016 12 15; 214(12):1796-1799.
Score: 0.132
-
Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NTH, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol. 2015 Feb; 16(2):170-177.
Score: 0.117
-
Nguyen TH, Nguyen TH, Vu TT, Farrar J, Hoang TL, Dong TH, Ngoc Tran V, Phung KL, Wolbers M, Whitehead SS, Hibberd ML, Wills B, Simmons CP. Corticosteroids for dengue - why don't they work? PLoS Negl Trop Dis. 2013; 7(12):e2592.
Score: 0.109
-
Carod-Artal FJ, Wichmann O, Farrar J, Gasc?n J. Neurological complications of dengue virus infection. Lancet Neurol. 2013 Sep; 12(9):906-919.
Score: 0.107
-
Tricou V, Vu HT, Quynh NV, Nguyen CV, Tran HT, Farrar J, Wills B, Simmons CP. Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect Dis. 2010 May 28; 10:142.
Score: 0.086
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|